Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 256 studies with search of: | "Aldesleukin" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
|
||||
2 | Recruiting |
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
|
||||
3 | Not yet recruiting |
Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
|
||||
4 | Completed |
A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
|
||||
5 | Recruiting |
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-Risk Melanoma Patients
|
||||
6 | Completed |
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
|
||||
7 | Active, not recruiting |
An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients
|
||||
8 | Recruiting |
Laboratory-Treated Autologous Peripheral Blood Lymphocytes, Aldesleukin, Cyclophosphamide, and Fludarabine in Treating Patients With Metastatic Melanoma
|
||||
9 | Active, not recruiting |
Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
|
||||
10 | Recruiting |
Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer
|
||||
11 | Terminated |
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
|
||||
12 | Recruiting |
Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
|
||||
13 | Completed |
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
|
||||
14 | Completed |
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
|
||||
15 | Recruiting |
Aldesleukin in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
|
||||
16 | Recruiting |
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
|
||||
17 | Recruiting |
Vaccine Therapy and Aldesleukin in Treating Women With Metastatic Breast Cancer
|
||||
18 | Not yet recruiting |
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
|
||||
19 | Active, not recruiting |
Interferon-Gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
|
||||
20 | Active, not recruiting |
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |